- Issuer ticker
-
MIRM
- Reported as of
-
06 Oct 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
06 Oct 2026, 20:38:23 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Judit Ryvkin, Attorney-in-Fact
Filing notes and source
Key filing fact
Christopher Peetz filed Form 4 for Mirum Pharmaceuticals, Inc. (MIRM) on 06 Oct 2026.
Key facts
- This page summarizes Christopher Peetz's Form 4 filing for Mirum Pharmaceuticals, Inc. (MIRM).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 06 Oct 2026, 20:38.
Change
- Previous filing in this sequence was filed on 03 Sep 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001614740
Primary reporting owner
Peetz Christopher
- Relationship
-
CHIEF EXECUTIVE OFFICER, Director
- Address
- C/O MIRUM PHARMACEUTICALS, INC., 989 E HILLSDALE BLVD., SUITE 300, FOSTER CITY
- Signature
- /s/ Judit Ryvkin, Attorney-in-Fact
- Signature date
- 06 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MIRM
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +5,305
- Change %
- +2.7%
- Price
-
$19.19*
- Shares after
- 199,745
- Date
- 06 Oct 2026
- Ownership
- Direct
MIRM
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +6,892
- Change %
- +3.5%
- Price
-
$15.87*
- Shares after
- 206,637
- Date
- 06 Oct 2026
- Ownership
- Direct
MIRM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 187,500
- Date
- 06 Oct 2026
- Ownership
- By The Peetz Family Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MIRM
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -5,305
- Change %
- -3%
- Price
-
$0.000000*
- Shares after
- 169,695
- Date
- 06 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,305
- Exercise price
- $19.19
- Footnotes
- F1
MIRM
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -6,892
- Change %
- -2.9%
- Price
-
$0.000000*
- Shares after
- 233,108
- Date
- 06 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,892
- Exercise price
- $15.87
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote